Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma
about
Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerLimited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancerSignificance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinomaUpdate on thyroid cancer treatment.Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.Oncologic Safety of Robot Thyroid Surgery for Papillary Thyroid Carcinoma: A Comparative Study of Robot versus Open Thyroid Surgery Using Inverse Probability of Treatment Weighting.Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatmentAntithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer.Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma?Contemporary management of papillary carcinoma of the thyroid gland.Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma.A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases.The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management.Robotic thyroidectomy by bilateral axillo-breast approach: review of 1,026 cases and surgical completeness.Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.Recombinant human thyrotropin-stimulated thyroglobulin level at the time of radioactive iodine ablation is an independent prognostic marker of differentiated thyroid carcinoma in the setting of prophylactic central neck dissection.Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation.Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.Elevated serum thyroglobulin levels at the time of ablative radioactive iodine therapy indicate a worse prognosis in thyroid cancer: an Australian retrospective cohort study.Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.Evaluation of whole-body retention of iodine-131 ((131)I) after postoperative remnant ablation for differentiated thyroid carcinoma - thyroxine withdrawal versus rhTSH administration: A retrospective comparison.Response to initial therapy of differentiated thyroid cancer predicts the long-term outcome better than classical risk stratification systems.Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy.Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma.Technical and oncologic safety of robotic thyroid surgery.Surgical outcomes of robotic thyroid surgery using a double incision gasless transaxillary approach: analysis of 400 cases treated by the same surgeon.Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer.Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: Behavior and therapeutic implications.Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.Stimulated Serum Thyroglobulin Levels versus Unstimulated Serum Thyroglobulin in the Follow-up of Patients with Papillary Thyroid Carcinoma.Therapeutic outcomes of papillary thyroid cancer patients in different risk groups.
P2860
Q26765083-337A4279-AE82-40C2-84D9-68EE92990313Q30367068-CAE6B5CA-D1D0-42D5-9888-A5A4A9E38B81Q33669903-260B835B-B5E2-400F-9B1E-E420D8ECA153Q34260830-008F3B2D-7B76-487D-93C2-5803A6693A26Q34310219-44B8108F-0B16-40AB-8D31-38D7147D168DQ35653514-06F50852-BC98-4301-A61C-F1082802D364Q35843018-80A9779B-2896-494E-9B7D-CE46992B4AEDQ36048344-3AAA62AB-C9CA-4B3D-AD3D-008E4F2171B8Q36064573-6954820C-4066-480B-B979-90FA8F5216FDQ36124278-A3B6667A-E76E-4882-A97A-D6FFEC5E0C62Q36285155-3B057145-C95D-4FFF-991D-96DD61237C3BQ37084125-FD8A0282-C901-4380-8BEE-D8C9C50C5665Q37165535-D62E771A-DED9-42EE-BDED-FF34770B2C7AQ37411175-C990A90B-183B-4AAA-AC5C-0E5C3AF37687Q37585292-39BCF132-8568-465D-AB74-0B737D690416Q37656285-E9DE89D4-0A36-423E-880B-87D7F5D0C07FQ37736769-1843A39C-C75B-4D3E-9763-AA6131F8ECACQ37815386-7BC03A97-62E2-4FE0-B7BE-5B232944B534Q38084191-0124DDCB-A898-4D41-A32F-275AC0CCFC6CQ38168704-6E60B781-6544-44D8-89B5-E612A30C82E1Q38417634-F2D156EE-0817-4067-958D-80FC9ED5BEB7Q38563685-A17B9EC0-13C9-4405-8C53-CF5E35047F29Q38571991-73F09358-2105-4F6D-8F1D-0E9D98D9571DQ38600499-D73ACE26-0ECA-4634-B4A5-34D7FB86166FQ38917535-ACA05D36-207B-4EB5-9E45-FDC781A28680Q39103120-85D58798-BC26-4FCE-9FE3-81DDBC654CAEQ41050094-7557DE3C-355D-468E-9536-DF3EF3A1BE83Q41771255-DD126DD7-BEB3-4652-876D-D7F4116ABAF7Q42012375-74EDDC25-6B7D-48B2-9837-B8385BA748A8Q42094673-2F04E196-56F4-4D4D-85AC-5CE0A37AC431Q42474502-60E98D86-FBC2-4149-A2FA-FA76DA1DA193Q42491619-98544008-57C9-4255-A346-5E267B5C917EQ43746499-41AE3861-12B1-4246-BDB0-40DB463855F1Q45154447-5D8A446A-18BC-4FFA-9CC1-7306455A0E8AQ45731055-460110BB-F5F9-4B2F-B163-D59554C5860AQ45918348-04E8FAEA-9805-4776-8C09-8C8DE096C882Q47417828-CC28DB08-2338-499B-B8CC-F8918B056C44Q48126648-18D6E169-42E7-409C-BF37-7E39603E379DQ49336881-65069DE6-F3BE-4DB0-9677-2D87EA9B19ABQ51026868-07AE0D88-5E9D-4E9F-85C3-02CDEC3F444B
P2860
Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma
description
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2005
@uk
name
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@en
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@nl
type
label
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@en
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@nl
prefLabel
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@en
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@nl
P2093
P50
P356
P1476
Serum Thyroglobulin Levels at ...... fferentiated Thyroid Carcinoma
@en
P2093
Eun Sook Kim
Jeong Seok Yeo
Jin Sook Ryu
Seong Chul Kim
Suck Joon Hong
P304
P356
10.1210/JC.2004-1771
P407
P577
2005-03-01T00:00:00Z